Loading portfolio…
| # | Issuer | Value | Shares | % Portfolio |
|---|---|---|---|---|
| 1 | CG ONCOLOGY INC | $431.2M | 6371669 | 65.21% |
| 2 | Nuvation Bio Inc. | $111.3M | 25954439 | 16.84% |
| 3 | Upstream Bio Inc. | $24.5M | 2724868 | 3.71% |
| 4 | Aclaris Therapeutics, Inc. | $15.2M | 4041736 | 2.29% |
| 5 | AARDVARK THERAPEUTICS INC | $14.8M | 3917299 | 2.23% |
| 6 | Lyell Immunopharma, Inc. | $13.9M | 692050 | 2.10% |
| 7 | NEWAMSTERDAM PHARMA CO NV | $10.4M | 325057 | 1.57% |
| 8 | Arcus Biosciences, Inc | $10.3M | 477819 | 1.56% |
| 9 | REVOLUTION MEDICINES INC(NSM) | $9.1M | 93500 | 1.37% |
| 10 | Equillium Inc. | $8.9M | 4447308 | 1.35% |
| 11 | BeyondSpring Inc. | $6.2M | 3800702 | 0.94% |
| 12 | Zentalis Pharmaceuticals Inc. | $3.1M | 1323327 | 0.47% |
| 13 | KRYSTAL BIOTECH INC | $1.9M | 7300 | 0.29% |
| 14 | Pyxis Oncology, Inc (formerly Apexigen) | $477K | 326810 | 0.07% |
Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.